About
Technology
Issues
FAQ
Links
Official Page
Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.